Grantham, Mayo, Van Otterloo & Co (GMO)’s RR Donnelley & Sons Co. RRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-136,600
Closed -$1.54M 792
2021
Q4
$1.54M Sell
136,600
-24,300
-15% -$211K 0.01% 499
2021
Q3
$827K Buy
+160,900
New +$858K ﹤0.01% 551
2019
Q4
Sell
-51,500
Closed -$194K 788
2019
Q3
$194K Sell
51,500
-42,700
-45% -$102K ﹤0.01% 699
2019
Q2
$186K Sell
94,200
-185,700
-66% -$613K ﹤0.01% 683
2019
Q1
$1.32M Buy
279,900
+188,400
+206% +$971K 0.01% 448
2018
Q4
$362K Buy
91,500
+41,700
+84% +$217K ﹤0.01% 470
2018
Q3
$269K Hold
49,800
﹤0.01% 491
2018
Q2
$287K Hold
49,800
﹤0.01% 512
2018
Q1
$435K Sell
49,800
-2,200
-4% -$18.2K ﹤0.01% 491
2017
Q4
$484K Buy
52,000
+22,000
+73% +$201K ﹤0.01% 461
2017
Q3
$309K Buy
30,000
+5,400
+22% +$55.9K ﹤0.01% 475
2017
Q2
$308K Buy
+24,600
New +$303K ﹤0.01% 464
2017
Q1
Sell
-49,100
Closed -$801K 662
2016
Q4
$801K Buy
+49,100
New +$881K ﹤0.01% 387

Grantham, Mayo, Van Otterloo & Co (GMO)'s RRD Position: Q1 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of RR Donnelley & Sons Co. (RRD) in Q1 2022, closing a stake of 136,600 shares — an estimated $1.54M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in RRD in Q4 2016 and held it in 13 quarters. The position peaked at $1.54M in Q4 2021. 0 funds tracked by Wall St. Rank hold RRD as of Q1 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining RR Donnelley & Sons Co. position as of Q1 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 136,600 RR Donnelley & Sons Co. shares in Q1 2022, an estimated $1.54M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in RR Donnelley & Sons Co. in Q4 2016 and held it in 13 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s RR Donnelley & Sons Co. position peaked at $1.54M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held RR Donnelley & Sons Co. as of Q1 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2022, filed 13 May 2022.